Novel indication for myeloid progenitor use: induction of tolerance in solid organ transplantation
Ended Project Grant Awarded Last action
- Award ID
- R42AI108016
- Recipient
-
Cellerant Therapeutics, Inc. UEI LML1YE6L8KU3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $842,489
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$274,670 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $543,567 | |
| Amendment | $0 | |
| Original award | $573,592 |
Quick answers
Who received award R42AI108016?
R42AI108016 was awarded to Cellerant Therapeutics, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2013.
How much is award R42AI108016 worth?
$842,489 has been obligated on R42AI108016.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award